Tirzepatide: observed
61 studies: patients on it are followed, or it is given outside a trial. Page 1 of 1. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.
- Breath Acetone During Tirzepatide Treatment and Resistance Training in Adults With ObesityNot yet recruitingNCT07931235Report a problem
- Molecular and Microbiome Changes During Tirzepatide Treatment and Resistance Training in ObesityNot yet recruitingNCT07931196Report a problem
- Functional, Cognitive, and Behavioral Correlates of Resistance Training During Tirzepatide-Induced Weight LossNot yet recruitingNCT07929571Report a problem
- Ocular Changes in Patients Using Tirzepatide or SemaglutideRecruitingNCT07924618Report a problem
- Changes in Body Composition Following Pharmacological Treatment for Obesity.Enrolling by invitationNCT07908940Report a problem
- A Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapyNot yet recruitingNCT07881783Report a problem
- GLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without DiabetesRecruitingNCT07858864Report a problem
- Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese PatientsNot yet recruitingNCT07847515Report a problem
- NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World StudyNot yet recruitingNCT07846956Report a problem
- Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 DiabetesRecruitingNCT07835360Report a problem
- Real-World Outcomes of Tirzepatide in Pakistani Adults With Obesity, Prediabetes, and Type 2 DiabetesNot yet recruitingNCT07809568Report a problem
- GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF RegistryNot yet recruitingNCT07787936Report a problem
- Comparing Facial Aging Between Identical Twins With 3D ImagingNot yet recruitingNCT07760532Report a problem
- Salivary Function and Dental Changes During GLP-1 TherapyNot yet recruitingNCT07720466Report a problem
- Effects of GLP-1 RAs on Human Lactation OutcomesRecruitingNCT07720414Report a problem
- Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor AgonistsRecruitingNCT07702461Report a problem
- GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid ObesityNot yet recruitingNCT07668765Report a problem
- Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.RecruitingNCT07653412Report a problem
- Genetic, Microbiological and Behavioral Factors in ObesityRecruitingNCT07650149Report a problem
- Estimating the Impact of Obesity Medications on Clinical and Economic OutcomesEnrolling by invitationNCT07640139Report a problem
- Preoperative Optimization With Tirzepatide, Ketogenic Diet, or Standard Care Before One Anastomosis Gastric Bypass SurgeryNot yet recruitingNCT07622992Report a problem
- GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort StudyRecruitingNCT07588984Report a problem
- CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational RegistryNot yet recruitingNCT07567378Report a problem
- Safety and Effectiveness of Tirzepatide in Patients With Obesity at Hospital de Clínicas, ParaguayNot yet recruitingNCT07492563Report a problem
- Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical ClockNot yet recruitingNCT07444073Report a problem
- Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional StudyRecruitingNCT07398222Report a problem
- A Real-World Study on the Impact of Weight Loss on Treatment Efficacy in Overweight/Obese Patients With Plaque PsoriasisNot yet recruitingNCT07382388Report a problem
- Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKDRecruitingNCT07309094Report a problem
- Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss PatientsRecruitingNCT07229170Report a problem
- Research on Effects of Drugs on Body Composition and Function With Imaging in DiabetesNot yet recruitingNCT07156331Report a problem
- Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)Not yet recruitingNCT07099742Report a problem
- Tirzepatide vs Liraglutide in BoneRecruitingNCT07094568Report a problem
- Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in ObesityRecruitingNCT07042672Report a problem
- 24-h Energy Expenditure and Anti-obesity MedicationEnrolling by invitationNCT07041983Report a problem
- Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.Not yet recruitingNCT06856928Report a problem
- GLP-1 Receptor Agonists in the Surgical Patient: Prevalence, Epidemiology, and Pulmonary ComplicationsCompletedNCT07932119Report a problem
- Metabolic Effects of Switching From Injectable Semaglutide to TirzepatideActive, not recruitingNCT07889453Report a problem
- Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/ObesityCompletedNCT07701005Report a problem
- GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial EmulationWithdrawnNCT07677865Report a problem
- Tirzepatide-Based Prehabilitation Before Elective Ventral and Incisional Hernia Repair in Patients With ObesityCompletedNCT07638592Report a problem
- Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes.CompletedNCT07619508Report a problem
- Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With ObesityCompletedNCT07504172Report a problem
- INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)CompletedNCT07417618Report a problem
- Real-World Tirzepatide Therapy in Post-Bariatric Weight Regain and Preoperative Obesity PatientsCompletedNCT07382180Report a problem
- Spartina® (Tirzepatide) Effectiveness and Safety EvaluationCompletedNCT07262762Report a problem
- Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)CompletedNCT07203677Report a problem
- Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)Active, not recruitingNCT07188545Report a problem
- Comparison of Body Composition Changes With Weight Loss InterventionsActive, not recruitingNCT07115069Report a problem
- Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular RiskCompletedNCT07096063Report a problem
- Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims DataCompletedNCT07088718Report a problem
- Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection FractionActive, not recruitingNCT06980623Report a problem
- Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims DataCompletedNCT06914154Report a problem
- Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection FractionCompletedNCT06914141Report a problem
- Study of Patients Being Treated With Anti-obesity MedicationActive, not recruitingNCT06790160Report a problem
- Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesCompletedNCT06779929Report a problem
- A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight LossCompletedNCT06761703Report a problem
- Effects of Tirzepatide on Blood, Imaging and Breast Tissue BiomarkersCompletedNCT06485089Report a problem
- CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist UsersActive, not recruitingNCT06467604Report a problem
- The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.WithdrawnNCT06354101Report a problem
- Role Of Metabolic Adaptation In Weight RegainCompletedNCT05766358Report a problem
- Anti-obesity Pharmacotherapy and InflammationActive, not recruitingNCT05756764Report a problem